Mburu A, Laving A, Macharia W, Sande J
BMJ Open Gastroenterol. 2023; 10(1).
PMID: 36796875
PMC: 9936283.
DOI: 10.1136/bmjgast-2022-001044.
Scapaticci S, DAdamo E, Mohn A, Chiarelli F, Giannini C
Front Endocrinol (Lausanne). 2021; 12:639548.
PMID: 33889132
PMC: 8056131.
DOI: 10.3389/fendo.2021.639548.
van Hoeve K, Mekahli D, Morava E, Levtchenko E, Witters P
Pediatr Nephrol. 2017; 33(6):957-971.
PMID: 28646278
DOI: 10.1007/s00467-017-3715-3.
Cannito S, Morello E, Bocca C, Foglia B, Benetti E, Novo E
PLoS One. 2017; 12(3):e0172575.
PMID: 28249038
PMC: 5331985.
DOI: 10.1371/journal.pone.0172575.
Martin-Calvo N, Moreno-Galarraga L, Martinez-Gonzalez M
Nutrients. 2016; 8(8).
PMID: 27556485
PMC: 4997425.
DOI: 10.3390/nu8080512.
[Waist circumference as a marker for screening nonalcoholic fatty liver disease in obese adolescents].
Clemente A, Molin Netto B, de Carvalho-Ferreira J, Campos R, Ganen A, Tock L
Rev Paul Pediatr. 2016; 34(1):47-55.
PMID: 26830602
PMC: 4795721.
DOI: 10.1016/j.rpped.2015.05.007.
Lipid-induced hepatocyte-derived extracellular vesicles regulate hepatic stellate cell via microRNAs targeting PPAR-γ.
Povero D, Panera N, Eguchi A, Johnson C, Papouchado B, Horcel L
Cell Mol Gastroenterol Hepatol. 2016; 1(6):646-663.e4.
PMID: 26783552
PMC: 4714359.
DOI: 10.1016/j.jcmgh.2015.07.007.
Non-alcoholic fatty liver disease: The diagnosis and management.
Abd El-Kader S, El-Den Ashmawy E
World J Hepatol. 2015; 7(6):846-58.
PMID: 25937862
PMC: 4411527.
DOI: 10.4254/wjh.v7.i6.846.
Non-alcoholic Fatty liver disease in children.
Singer C, Stancu P, Cosoveanu S, Botu A
Curr Health Sci J. 2015; 40(3):170-6.
PMID: 25729601
PMC: 4340436.
DOI: 10.12865/CHSJ.40.03.03.
Biochemical, anthropometric and body composition indicators as predictors of hepatic steatosis in obese adolescents.
Gobato A, Vasques A, Yamada R, Zambon M, Barros-Filho A, Hessel G
Rev Paul Pediatr. 2014; 32(2):230-6.
PMID: 25119755
PMC: 4183024.
DOI: 10.1590/0103-0582201432215813.
The association of PNPLA3 variants with liver enzymes in childhood obesity is driven by the interaction with abdominal fat.
Del Giudice E, Grandone A, Cirillo G, Santoro N, Amato A, Brienza C
PLoS One. 2011; 6(11):e27933.
PMID: 22140488
PMC: 3225386.
DOI: 10.1371/journal.pone.0027933.
Adiponectin, a key adipokine in obesity related liver diseases.
Buechler C, Wanninger J, Neumeier M
World J Gastroenterol. 2011; 17(23):2801-11.
PMID: 21734787
PMC: 3120939.
DOI: 10.3748/wjg.v17.i23.2801.
Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease.
Tannapfel A, Denk H, Dienes H, Langner C, Schirmacher P, Trauner M
Virchows Arch. 2011; 458(5):511-23.
PMID: 21442288
DOI: 10.1007/s00428-011-1066-1.
Histopathology of nonalcoholic fatty liver disease.
Brunt E, Tiniakos D
World J Gastroenterol. 2010; 16(42):5286-96.
PMID: 21072891
PMC: 2980677.
DOI: 10.3748/wjg.v16.i42.5286.
Fatty liver disease in children: eat now pay later.
De Bruyne R, Fitzpatrick E, Dhawan A
Hepatol Int. 2010; 4(1):375-85.
PMID: 20305757
PMC: 2836438.
DOI: 10.1007/s12072-009-9160-z.
[Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease. Grade 2 consensus-based guidelines].
Tannapfel A, Denk H, Dienes H, Langner C, Schirmacher P, Trauner M
Pathologe. 2010; 31(3):225-37.
PMID: 20221762
DOI: 10.1007/s00292-010-1274-5.
Nonalcoholic fatty liver disease in children living in the obeseogenic society.
A-Kader H
World J Pediatr. 2009; 5(4):245-54.
PMID: 19911138
DOI: 10.1007/s12519-009-0048-8.
Diagnosis and treatment of pediatric nonalcoholic steatohepatitis and the implications for bariatric surgery.
Pardee P, Lavine J, Schwimmer J
Semin Pediatr Surg. 2009; 18(3):144-51.
PMID: 19573756
PMC: 2761012.
DOI: 10.1053/j.sempedsurg.2009.04.004.